Cargando…
Advances and Insights of APC-Asef Inhibitors for Metastatic Colorectal Cancer Therapy
In Colorectal cancer (CRC), adenomatous polyposis coli (APC) directly interacts with the Rho guanine nucleotide exchange factor 4 (Asef) and releases its GEF activity. Activated Asef promotes the aberrant migration and invasion of CRC cell through a CDC42-mediated pathway. Knockdown of either APC or...
Autores principales: | Yang, Xiuyan, Zhong, Jie, Zhang, Qiufen, Feng, Li, Zheng, Zhen, Zhang, Jian, Lu, Shaoyong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100458/ https://www.ncbi.nlm.nih.gov/pubmed/33968990 http://dx.doi.org/10.3389/fmolb.2021.662579 |
Ejemplares similares
-
Rational design of a sensitivity-enhanced tracer for discovering efficient APC–Asef inhibitors
por: Zhong, Jie, et al.
Publicado: (2022) -
Conformational Selection Mechanism Provides Structural Insights into the Optimization of APC-Asef Inhibitors
por: He, Xinheng, et al.
Publicado: (2021) -
Venetoclax is a potent hepsin inhibitor that reduces the metastatic and prothrombotic phenotypes of hepsin-expressing colorectal cancer cells
por: Rodenas, Maria Carmen, et al.
Publicado: (2023) -
Identification of a novel CNV at the APC gene in a Chinese family with familial adenomatous polyposis
por: Li, Juyi, et al.
Publicado: (2023) -
Opto-APC: Engineering of cells that display phytochrome B on their surface for optogenetic studies of cell-cell interactions
por: Russ, Marissa, et al.
Publicado: (2023)